The U.S. Preventive Services Task Force has issued a new guideline stating that women should begin having yearly mammograms at the age of 50. The new guideline updates a 2009 suggestion that says women should begin having mammograms every other year starting at the age of 50. This change, in fact, marks the third shift in thinking about mammograms in the last decade.
Taking too many vitamin supplements could actually increase the risk of cancer and other illnesses, according to a new study from researchers at the University of Colorado Cancer. For the study researchers examined any links between excessive use of specific supplements and increases in cancer risk. They found that folic acid supplements were linked with a twenty percent increased risk.
A new pair of clinical trials suggest that immune system drugs can help treat advanced melanoma. In the studies, researchers found that the immune checkpoint inhibitor Keytruda worked better than the current frontline treatment for melanoma, Yervoy. They also found that using both drugs together yielded better results than using Yervoy alone.
A new form of blood test called a liquid biopsy could prove more effective than traditional biopsies, according to a new study from researchers at the Memorial Sloan Kettering Cancer Center. With the new blood test doctors can seek out tiny fragments of DNA that are shed by tumor cells in the blood stream.
New research suggests that breast cancer rates in the U.S. may rise by 50 percent by 2030. A new study by the National Cancer Institute on cancer projections found that breast cancer rates would increase to an estimated 441,000 in 2030 (compared to 283,000 in 2011), with rates of estrogen-receptor positive cancers that had not spread to other parts of the body.
Some fish oils could counteract the effects of chemotherapy, according to a new study from researchers in Holland. They found that oils from several fish including herring, mackerel and three other fish increased the levels of a potentially dangerous fatty acid in mice with cancer. They found specifically that those mice taking any of these fish oils had a spike in a fatty acid called 16:4(n-3).
New research suggests that an increased risk of malignant melanoma may be linked to cheap vacation packages. According to the new study, released by Cancer Research UK, approximately 5,700 retirees in Great Britain are diagnosed malignant melanoma each year, compared to 600 in the mid-1970s. The study also shows that older men in Great Britain are around 10 times more likely to be diagnosed.
A new form of MRI technology that can detect sugar may help improve cancer detection and decrease the need for invasive procedures, according to a new study from researchers at Johns Hopkins. The new technology images not only uncover the proteins in potential tumors, but also the glucose surrounding those tumors to create more defined images.
Drinking coffee regularly could help repair damage in the liver caused by drinking alcohol in excess, according to a new study from researchers at the World Cancer Research Fund. For the study the group reviewed data collected in 34 studies including more than eight million participants. For every cup of coffee consumed, there was a roughly 14 percent decreased chance of liver cancer.
Vitamin D supplements may slow or reverse the development of prostate cancer tumors, according to a new study from researchers at the Medical University of South Carolina in Charleston. For the study the researchers enrolled 37 men who elected to have their prostates removed because of low-grade tumors. Men who were given a Vitamin D supplement for at least 60 days showed some improvement.
A new study finds that certain painkillers may lower colon cancer risk, but their effect may depend on a person's genetics. Researchers examined studies conducted between 1976 and 2011 of more than 19,000 people and found that those who used certain painkillers (aspirin, naproxen, and ibuprofen, among others) were less likely to develop colon cancer than those who didn't use the drugs.
Scientists are questioning the accuracy of breast biopsies in making correct diagnoses in cases of cancer or tissue abnormalities. In a new study, researchers examined the work of 115 pathologists and 240 breast biopsy specimens. They found that abnormal, precancerous cells were only identified half the time.